Global Anaphylaxis Industry Outlook 2025-2029: Market Set to Cross $4.78 Billion Milestone

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Anaphylaxis Market Size By 2025?
The market specifically addressing anaphylaxis has experienced robust expansion over the most recent years, projected to increase from USD 3.24 billion in 2024 to reach USD 3.5 billion in 2025, reflecting an 8.1% compound annual growth rate. This upswing during the review period stems from several key factors, including the escalating incidence of allergies to foodstuffs, heightened public and professional consciousness regarding anaphylactic reactions, enhancements in medical facilities and frameworks, improved methods for identification and handling of the condition, alongside the greater accessibility of epinephrine auto-injector devices.

How Big Is the Anaphylaxis Market Size Expected to Grow by 2029?
Anticipating robust expansion, the market addressing anaphylaxis is projected to achieve a valuation of $4.78 billion by 2029, climbing steadily at an annual compounded growth rate of 8.1% throughout the duration of the forecast. This upward trajectory is fueled by several key factors, such as escalating trends in city living and shifts in daily habits, a higher frequency of documented anaphylaxis incidents, expanding purchasing power in developing economies, financial support from governmental bodies directed toward allergy investigations, and advancements in the mechanisms used for delivering urgent care. Furthermore, significant shifts shaping the market during this span include a heightened need for self-administered injection devices, the incorporation of digital healthcare technologies into how anaphylaxis is overseen, greater attention paid to making treatment options accessible financially, the proliferation of preventive measures and associated vaccines, and a greater utilization of biological agents in treating allergic conditions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Key Market Drivers Powering Anaphylaxis Market Expansion and Growth?
Anticipated increases in the frequency of adverse reactions to food are poised to boost the expansion of the anaphylaxis market moving ahead. Since food allergies involve immune system responses triggered by specific comestibles, they manifest in a spectrum of symptoms, potentially leading to severe anaphylaxis in extreme cases. These elevated rates of food allergies stem from shifts in eating patterns, external environmental pressures, and greater recognition and diagnostic capabilities. Therapy for anaphylaxis serves as a vital, emergency measure for those suffering from food allergies, swiftly counteracting dangerous allergic episodes by alleviating signs like constricted airways, edema, and hypotension, thereby ensuring rapid stabilization and averting fatalities, while simultaneously equipping individuals to respond promptly during subsequent allergic events. To illustrate, data circulated in September 2024 by the World Health Organization (WHO), a specialized agency of the United Nations (UN) situated in Switzerland, indicated that approximately 220 million persons worldwide currently grapple with food allergies. Given that a solitary food item might contain numerous allergenic components, individuals frequently exhibit hypersensitivity to several different foodstuffs. Furthermore, findings detailed in May 2024 within the Patterns and Prevalence of Adult Food Allergy (PAFA) study, released by the Food Standards Agency (FSA), a UK governmental body, showed that upwards of 30% of the adult population experienced unfavorable reactions related to food, with clinical evaluations substantiating food allergies in roughly 6% of UK adults, translating to an estimated 2.4 million individuals. Consequently, the growing incidence of food allergies acts as a catalyst for the progression of the anaphylaxis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Anaphylaxis Market?
Leading firms within the anaphylaxis sector are heavily invested in pioneering superior epinephrine nasal spray formulations designed for expedited and more effective pharmaceutical administration in urgent situations.This medical instrument dispenses epinephrine (adrenaline) via the nasal route to address acute allergic responses, such as anaphylaxis.Specifically, in August of 2024, ARS Pharmaceuticals, a US biotechnology entity, received sanction from the Food and Drug Administration, a US regulatory body, for their product Neffy (epinephrine nasal spray), establishing it as the sole, inaugural non-injectable therapy available for managing type I allergic events, including anaphylaxis.This novel nasal application presents a less intrusive substitute compared to conventional epinephrine autoinjectors, potentially furnishing a more readily available recourse for emergency intervention.The objective behind Neffy is to enhance patient adherence by circumventing the necessity of an injection while ensuring prompt, life-saving epinephrine delivery during critical allergic episodes.

What Are the Emerging Segments in the Anaphylaxis Market?
The anaphylaxismarket covered in this report is segmented -

1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class
2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration
3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications

Subsegments:
1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials
2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Who Are the Global Leaders in the Anaphylaxis Market?
Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Which are the Top Profitable Regional Markets for the Anaphylaxis Industry?
North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21096

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.